Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

Condition:   Systemic Lupus Erythematosus Interventions:   Drug: Sirolimus;   Drug: Placebo Sponsors:   Chinese SLE Treatment And Research Group;   Beijing Municipal Science & Technology Commission;   North China Pharmaceutical Group Corporation Not yet recruiting

Source: ClinicalTrials.gov - October 9, 2020 Category: Research Source Type: clinical trials